- Open Access
Synthesis of an antiviral drug precursor from chitin using a saprophyte as a whole-cell catalyst
Microbial Cell Factories volume 10, Article number: 102 (2011)
Recent incidents, such as the SARS and influenza epidemics, have highlighted the need for readily available antiviral drugs. One important precursor currently used for the production of Relenza, an antiviral product from GlaxoSmithKline, is N-acetylneuraminic acid (NeuNAc). This substance has a considerably high market price despite efforts to develop cost-reducing (biotechnological) production processes. Hypocrea jecorina (Trichoderma reesei) is a saprophyte noted for its abundant secretion of hydrolytic enzymes and its potential to degrade chitin to its monomer N-acetylglucosamine (GlcNAc). Chitin is considered the second most abundant biomass available on earth and therefore an attractive raw material.
In this study, we introduced two enzymes from bacterial origin into Hypocrea, which convert GlcNAc into NeuNAc via N-acetylmannosamine. This enabled the fungus to produce NeuNAc from the cheap starting material chitin in liquid culture. Furthermore, we expressed the two recombinant enzymes as GST-fusion proteins and developed an enzyme assay for monitoring their enzymatic functionality. Finally, we demonstrated that Hypocrea does not metabolize NeuNAc and that no NeuNAc-uptake by the fungus occurs, which are important prerequisites for a potential production strategy.
This study is a proof of concept for the possibility to engineer in a filamentous fungus a bacterial enzyme cascade, which is fully functional. Furthermore, it provides the basis for the development of a process for NeuNAc production as well as a general prospective design for production processes that use saprophytes as whole-cell catalysts.
NeuNAc is the most prevalent exponent of sialic acids . In mammals, sialic acids are usually found as terminal residues of glycol conjugates on the outermost cell surface. As a result of their location and their negative carboxylate functionality, sialic acids play important roles in mediating cellular recognition and adhesion processes  and in the infection cycles of severe viral diseases, such as influenza viruses A and B . In these cases, de novo- synthesized viral particles attach to their respective sialic acids at the cell surface. Neuraminidase (sialidase) activity is needed for the propagation of the virus in the host. Consequently, sialic acid derivatives are successfully applied in the therapy of such virus-related diseases. One well-known product that functions as a neuraminidase inhibitor is Relenza. Its active pharmaceutical ingredient is Zanamivir, which is a direct derivative of the NeuNAc precursor .
Traditionally, NeuNAc is prepared through extraction from natural sources, such as bird nests, milk, or eggs , through the hydrolysis of colominic acid (a homopolymer of NeuNAc) in a culture broth of Escherichia coli K1 , or through chemical synthesis . Methods for NeuNAc production have included a chemo-enzymatic process [8, 9], a two-enzyme reaction process [10, 11], a biotransformation process using E. coli, and an E. coli whole-cell system . However, the requirement for ATP or an excess of pyruvate and the subsequent expensive downstream processing has kept the costs of NeuNAc production considerably high (current market price is $100/g).
Chitin is considered the second most abundant biomass available on earth . The estimated annual biosynthesis of chitin is more than 1011 tons in marine waters alone . Unlike cellulose, the other dominant biopolymer, chitin can serve as a source for both carbon and nitrogen (C:N = 8:1) . This property suggests that chitin is an optimal resource for the production of NeuNAc (C:N = 11:1) because no additional nitrogen would need to be applied as it would be if glucose or cellulose were used as raw material. Chitin is found in the exoskeletons of arthropods, such as crustaceans (including crab, lobster, and shrimp) and insects (including ants and beetles), the cell walls of fungi, the radula of mollusks, and the beaks of cephalopods (including squid and octopi). This polymer is composed of β-(1,4)-linked units of the amino sugar N-acetylglucosamine (GlcNAc) that is currently produced using hydrolysis of deproteinized and demineralized crustacean shells . Chitinolytic enzymes from fungi of the genus Hypocrea have been extensively studied for decades . More recently, the chitinolytic enzyme system of H. jecorina has been studied using genome-wide analysis [19, 20]. Unlike their bacterial counterparts (e.g., Serratia marcescens), Hypocrea chitinolytic preparations have a high ratio of exochitinase to endochitinase activity and almost exclusively release monomeric GlcNAc from chitin , which is another advantageous aspect of chitin compared to cellulose. Nevertheless, this raw material has not been adequately used. Therefore, the basic premise of this study was to exploit the potential of a saprophytic fungus to degrade the cheap biowaste chitin to its monomer GlcNAc and to further metabolize this product to NeuNAc.
Results and Discussion
Engineering a NeuNAc synthesis pathway into Hypocrea
The biosynthesis of NeuNAc begins with the formation of N-acetylmannosamine (ManNAc) from GlcNAc or UDP-N-acetylglucosamine (UDP-GlcNAc). In mammals, ManNAc is then phosphorylated to give ManNAc-6-phosphate (ManNAc-6P). The second step involves the condensation of either ManNAc (in bacteria) or MacNAc-6P (in mammals) with phosphoenolpyruvate (PEP) to give NeuNAc or NeuNAc-9P, respectively. In mammals, NeuNAc-9P is then dephosphorylated to generate NeuNAc (see Figure 1). Hypocrea naturally degrades chitin almost exclusively to GlcNAc . Therefore, the challenge was to engineer a pathway to convert GlcNAc to NeuNAc via ManNAc, which would enable the use of Hypocrea as a whole-cell catalyst.
Lee and coworkers found that whole-cell extracts of several photobacteria could convert GlcNAc to ManNAc . Among them, Anabaena sp. CH1 exhibited the highest GlcNAc 2-epimerase activity; consequently, they cloned and characterized a gene encoding GlcNAc 2-epimerase from Anabaena sp. CH1 (E.C. 188.8.131.52) , which was used in the present study as a Hypocrea codon-optimized gene. For the second step (the condensation of ManNAc to NeuNAc), the currently used enzyme-catalyzed processes use a lyase, which requires an excess of pyruvate. Use of this incurs high downstream processing costs. Therefore, we used the NeuNAc synthase (EC 184.108.40.206) from Campylobacter jejuni in the Hyprocrea process. This enzymatic step entails the use of PEP instead of pyruvate, which in the intended in vivo process is supplied by the fungus, thereby leading to an irreversible and more efficient reaction towards NeuNAc . Moreover, the need for an excess of pyruvate becomes obsolete, and the resulting downstream process is significantly simplified. Similar to the GlcNAc 2-epimerase, the coding sequence for the NeuNAc synthase was codon-optimized for the usage in Hypocrea. The synthetic pathway is presented in Figure 1. The complete nucleotide sequences for both genes encoding the recombinant enzymes, tbage and tneub, are shown in additional file 1.
Metabolization or uptake of NeuNAc can not be observed in Hypocrea
As the ability of the fungus to metabolize NeuNAc is an important issue, a possible uptake of NeuNAc by H. jecorina was investigated. Therefore, the fungus was pre-grown on glycerol in liquid culture, and half of the mycelium was autoclaved and half of it was harvested. The dead and living mycelia were transferred to glycerol-containing medium to study growth conditions or to medium without a carbon source to study resting cell conditions. NeuNAc was added to both media, and cultures were incubated for 8 h. Supernatants from all conditions were analyzed after incubation for 0 and 8 h by HPLC after derivatization using 1,2-diamino-4,5-methylenedioxybenzene dihydrochloride (DMB). Similar amounts of NeuNAc were present under all conditions regardless of whether the fungus was alive or dead (Figure 2a). This result indicates that NeuNAc uptake does not occur in H. jecorina. As a positive control experiment we did a similar experiment but instead of NeuNAc, GlcNAc was added to the media. As can be inferred from Figure 2b GlcNAc was completely consumed after eight hours under both growth and resting cell conditions when the mycelium was viable.
Characterization of the recombinant H. jecorina strain
Recombinant Hypocrea strains were generated using protoplast transformation of H. jecorina QM9414. In the derived strains, the two Hypocrea codon-optimized genes (without GST-tag) were placed under the control of either the H. jecorina pyruvate kinase (pki) promoter, which is a strong constitutive promoter, or the H. jecorina xylanase 1 (xyn1) promoter, which is a strict shut-off system if an inducer (e.g. D-xylose) is missing. Such a system was used to avoid interference of the introduced recombinant pathway with cell wall biosynthesis and consequently, biomass formation. However, when comparing both promoter systems the strong pki promoter did not lead to decreased growth, diminished cell integrity or other adverse effects (data not shown). Therefore, we used strains in which both genes were under the control of the pki promoter for further studies as we observed a remarkably higher NeuNAc formation.
Transcriptional analysis of the recombinant H. jecorina strains was done by RT-qPCR to compare expression of both inserted genes using sar1 (SAR/ARF-type small GTPase) as a stable reference gene . Furthermore, the copy numbers of both genes was measured by qPCR of genomic DNA using pki as a reference, which in the native H. jecorina genome is present as a single copy gene. Based on these analyses a strain (termed PEC/PSC1) was chosen for further investigations because it showed the highest equal expression of both inserted genes. This was confirmed by the finding that this strain bears two copies of each recombinant gene in the genome. These data were also supported using Southern blot analysis (data not shown).
GlcNAc 2-epimerase and NeuNAc synthase are fully functional as GST-fusion proteins
Both recombinant enzymes were heterologously expressed as glutathione S-transferase (GST) fusion proteins in E. coli; the affinity chromatography purified proteins were used to confirm that their enzymatic capability was not altered by the codon usage adaptation and to provide a positive control for the enzymatic assays later on.
To determine if the recombinant enzymes were functional, both GST fusion proteins were used in an enzymatic assay. The presence of GlcNAc and the formation of the intermediate product ManNAc and the final product NeuNAc were monitored using HPLC-MS analysis and results are presented in Figure 3. Application of the GST-fusion proteins of both enzymes in the in vitro assay led to the formation of ManNAc and NeuNAc demonstrating that the synthetic genes are expressed as functional proteins (Figure 3a1 and 3b1).
NeuNAc synthesis in vitro by recombinant H. jecorina strains
According to the GST-fusion proteins, cell-free extracts of the recombinant H. jecorina strain PEC/PSC1 were applied in the enzymatic assay. The formation of ManNAc (Figure 3a2) and NeuNAc could be detected (Figure 3b2). This demonstrates that both enzymes are also fully functionally expressed in the recombinant H. jecorina strain PEC/PSC1. Neither ManNAc nor NeuNAc was detected using cell-free extracts from the parental strain in the assay (Figure 3a3 and 3b3), indicating that these pathways are normally not active in Hypocrea.
To investigate the stability of NeuNAc in cell-free extracts of the recombinant strain, according cell-free extracts obtained from the cultivation in a bioreactor on chitin (vide infra) were spiked with NeuNAc and incubated for 24 h. As a control, a heat-inactivated cell-free extract was similarly treated. Using HPLC analysis after derivatization with DMB, similar amounts of NeuNAc were detected in both extract preparations (Figure 3c), suggesting that components of the cell-free extract do not actively degrade NeuNAc. In addition, a similar amount of NeuNAc was measured in a NeuNAc-spiked cell-free extract of the recombinant strain that was not incubated, assuming that the 24-h incubation period at 30°C did not decrease the NeuNAc levels. As a final control, a cell-free extract without NeuNAc was also analyzed after a 24-h incubation period and, as expected, showed a lower amount of NeuNAc, which could only have resulted from its formation during the cultivation on chitin. In summary, we did not observe degradation of NeuNAc by H. jecorina. These data suggest that NeuNAc is not metabolized by the recombinant Hypocrea strain.
NeuNAc synthesis in vivo by the recombinant H. jecorina strain
We next addressed whether the recombinant H. jecorina strain had the ability to produce NeuNAc in vivo. To test this, the strain was grown on GlcNAc in shake flasks and cultivated on colloidal chitin in a bioreactor. Data on the corresponding cultivation monitoring are provided in additional file 2. As a positive control, an enzyme assay using the GST fusion proteins was again performed and resulted in the detection of ManNAc using HPLC-MS analysis as shown in Figure 4a1. Notably, the intermediate ManNAc was detected in the recombinant strain, regardless of the carbon source (Figure 4a2 und Figure 4a4), whereas the parental strain did not form ManNAc (Figure 4a3). In the parental strain, only the first metabolite, GlcNAc, was detected, and it was present because it was either directly used as a carbon source or formed by degradation of the biopolymer chitin due to the native chitinolytic activity of the fungus. The synthesis of the product NeuNAc was analyzed using HPLC-MS/MS analysis (Figure 4b). As a positive control, the reaction products (ManNAc, NeuNAc) generated by the use of the GST fusion proteins in an enzymatic assay are shown (Figure 4b1). Importantly, the recombinant H. jecorina strain formed NeuNAc using either carbon source, GlcNAc or chitin (Figure 4b2 and 4b4), whereas in the parental strain no formation of NeuNAc was detected (Figure 4b3). This analysis allowed us to estimate that 13 μg NeuNAc per g mycelium (dry weight) was formed in the recombinant strain. Thus, on its own, this would not be a competitive production process, but it does demonstrate the possibility for engineering a saprophyte and using it as a whole-cell catalyst that expresses a bacterial enzyme cascade. This method has enormous potential considering its use of a cheap starting material and the relatively simple, inexpensive cultivation of a fungus.
Taken together, we successfully engineered Hypocrea in a way that this fungus now produces NeuNAc from the biopolymer chitin by employing its natural saprophytic activity in combination with the introduction of a bacterial enzyme cascade. Because human society will face severe bottlenecks in the supply of energy and in obtaining certain raw materials in the upcoming years, we hope that this study will highlight the potential advantages of biopolymers, such as chitin, and stimulate their efficient usage. Furthermore, we anticipate that such strategies will support efforts to create sustainable production processes.
Strains and cultivation conditions
The parental strain H. jecorina (T. reesei) QM9414 (ATCC 26921) was maintained on malt extract (MEX) agar.
Mycelia for the enzymatic assay were cultivated in 3% (w/v) MEX medium using 108 conidia/L at 30°C.
Cultivation of H. jecorina on colloidal chitin was performed in a bench top bioreactor (Bioengineering, Wald, Switzerland) as previously described . Briefly, 500 mL Mandels-Andreotti (MA)  medium containing 1% (w/v) colloidal chitin , 0.5% GlcNAc, and 0.1% (w/v) bacto peptone (Difco, Detroit, US) was inoculated with 108 conidia/L. Some drops glanapon (Becker, Wien, Austria) were added to the medium to avoid excessive foam formation. Cultivation was performed at 30°C temperature, pH 5, 0.3 vvm aeration rate, and 500 rpm agitation rate for 96 h. Each sample drawing was followed by a microscopic analysis for infection control. Culture supernatant and mycelia were separated by filtration through GF/F glass microfiber filters (Whatman, Brentford, UK). All strains (parental, recombinant) showed similar growth on rich media as well as MA medium.
The synthetic gene tbage (for sequence see additional file 1) is based on the protein sequence of Anabaena sp. CH1 GlcNAc-2-epimerase (GenBank: ABG57042) and was reverse translated into a nucleotide sequence using the GeneOptimizer® software (Geneart, Regensburg, Germany). The codon usage was optimized for H. jecorina (http://www.kazusa.or.jp/codon). The synthetic gene tneub (for sequence see additional file 1) was similarly obtained based on the protein sequence from Campylobacter jejuni NCTC11168 NeuNAc synthase (http://old.genedb.org/genedb/cjejuni/index.jsp, Cj1141).
The synthetic genes tbage and tneub were excised from the production plasmid using Xba I/Nsi I digestion and inserted into pRLMex30  to generate the plasmids pMS-PEC and pMS-PSC.
For the construction of pGEX-epi and pGEX-syn, the oligonucleotides GEXfw and GEXrev (Table 1) were used to introduce an Xba I and Nsi I site into plasmid pGEX4T-2 (GE Healthcare, Chalfont St Giles, UK), yielding pGEX-MS. tbage and tneub were inserted into pGEX-MS via Xba I/Nsi I digestion to yield the plasmids pGEX-epi and pGEX-syn.
The protoplast transformation of H. jecorina was performed as described previously . The plasmid pHylox2 (2 μg) , which confers hygromycin B resistance , and 4 μg of each plasmid pMS-PEC and pMS-PSC were co-transformed into the fungal genome.
Fungal genomic DNA was isolated as described previously . Southern hybridization and detection were performed using the DIG High Prime DNA Labeling and Detection Starter Kit II following the manufacturer's instructions (Roche, Basel, Switzerland).
Glutathione S-transferase (GST) fusion proteins
GST fusion proteins of GlcNAc-2-epimerase and NeuNAc synthase were generated using plasmids pGEX-epi and pGEX-syn in E. coli BL21 (DE3). Purification of the proteins was performed using GSTrap™FF (GE Healthcare) according to standard procedures.
Harvested mycelia were ground into fine powder and resuspended in 0.1 M Bicine buffer (pH 8) containing protease inhibitors (2 μM leupeptin, 1 μM pepstatin A, and 10 μM PMSF) (0.3 g mycelia/mL). The suspension was sonicated using a Sonifier® 250 Cell Disruptor (Branson, Danbury, US) (power 40%, duty cycle 50%, power 20 sec, 40 sec pause, 10 cycles). Insoluble compounds were separated using centrifugation (10 min, 13000 g, 4°C). Enzymatic analysis was performed according to a previously described modified protocol . The assay was performed in a total volume of 100 μL containing 10 mM GlcNAc, 10 mM PEP, 12.5 mM MnCl2, 100 mM Bicine buffer (pH 8) and 40 μL cell-free extract. Reactions were incubated for 60 min at 37°C, terminated at 85°C for 10 min and analyzed using HPLC. As a positive control, 5 μL of both GST fusion proteins were applied in place of the cell-free extracts.
The stability of NeuNAc in the cell-free extract was determined by adding NeuNAc (150 μM) and incubating for 24 h at 30°C. After derivatization with DMB , the NeuNAc quantity was measured using HPLC.
Detection of NeuNAc synthesis in vivo
Harvested H. jecorina mycelia were ground into fine powder and resuspended in water (0.3 g mycelia/mL). The suspension was sonicated using a Sonifier® 250 Cell Disruptor (Branson) (power 70%, duty cycle 50%, power for 1 min, 1 min pause, 3 cycles). Insoluble compounds were separated using centrifugation (10 min, 13000 g, 4°C), and the supernatant was analyzed using HPLC-MS/MS.
NeuNAc and GlcNAc uptake
H. jecorina mycelia were pre-grown on MA containing 1% glycerol, transferred to MA medium containing 1% glycerol or no carbon source, spiked with 30 μM NeuNAc or GlcNAc, respectively, and incubated for 8 h at 30°C. Autoclaved mycelia served as a negative control. After derivatization with DMB , the NeuNAc quantity was measured using HPLC.
HPLC and HPLC-MS/MS analysis
NeuNAc, ManNAc and GlcNAc formation was measured using LC-MS (IT-TOF-MS) (Shimadzu, Kyoto, Japan) with a Rezex™ RHM-Monosaccharide H+-column (8%, 300 × 7.8 mm) (Phenomenex, Torrance, USA). The mobile phase consisted of water with 0.1% (v/v) trifluoroacetic acid, the flow was 0.6 mL/min, the column temperature was 80°C, and the injected volume was 10 μL. MS detection was performed in ESI+ mode, covering a scan range of 60-600 amu. The retention times were determined using pure standard substances. The identity of NeuNAc was confirmed by both, chromatographic retention time and mass spectral signal, which are very well matched by authentic standards of NeuNAc. The better the mass accuracy obtained from exact mass determination by HR-MS, the lower is the number of possible isobaric candidates (e.g. ). In this case the mass accuracy is better than 2 ppm, leading to the number of candidates reduced to less than 10, with an even further reduction in the number of potential candidates because the isotopic pattern is also taken into account (what the software of the used IT-TOF-MS instrument does automatically).
DMB derivatives of NeuNAc were separated on a Kinetex RP C18 (Phenomenex) at 0.75 mL/min with a 40°C column temperature and a mobile phase of water:methanol:trifluoroacetic acid (74.25:25:0.75). A Shimadzu RF-20AXS fluorescence detector (excitation 373 nm, emission 448 nm) was used for detection.
Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L: Biochemistry and Role of Sialic Acids. Biology of the Sialic Acids. Edited by: Rosenberg A. 1995, 7-67. NY and London: Plenum Press,
Varki A: Sialic acids as ligands in recognition phenomena. Faseb J. 1997, 11 (4): 248-255.
Herrler G, Hausmann J, Klenk HD: Sialic acid as receptor determinant of ortho-and paramyxoviruses. Biology of the Sialic Acids. Edited by: Rosenberg A. 1995, 315-331. NY and London: Plenum Press,
Tremblay JF: The other drug for avian flu. C&EN. 2006, 84 (15): 33-36.
Koketsu M, Juneja LR, Kawanami H, Kim M, Yamamoto T: Preparation of N-acetylneuraminic acid from delipidated egg yolk. Glycoconj J. 1992, 9 (2): 70-74. 10.1007/BF00731701
Maru I, Ohnishi J, Ohta Y, Tsukada Y: Why is sialic acid attracting interest now? Complete enzymatic synthesis of sialic acid with N-acylglucosamine 2-epimerase. J Biosci Bioeng. 2002, 93 (3): 258-265. 10.1263/jbb.93.258
de Ninno M: The synthesis and glycosidation of N-acetyl-D-neuraminic acid. Synthesis. 1991, 8: 583-593.
Blayer S, Woodley JM, Dawson MJ, Lilly MD: Alkaline biocatalysis for the direct synthesis of N-acetyl-D-neuraminic acid (Neu5Ac) from N-acetyl-D-glucosamine (GlcNAc). Biotechnol Bioeng. 1999, 66 (2): 131-136. 10.1002/(SICI)1097-0290(1999)66:2<131::AID-BIT6>3.0.CO;2-X
Mahmoudian M, Noble D, Drake CS, Middleton RF, Montgomery DS, Piercey JE, Ramlakhan D, Todd M, Dawson MJ: An efficient process for production of N-acetylneuraminic acid using N-acetylneuraminic acid aldolase. Enzyme Microb Technol. 1997, 20 (5): 393-400. 10.1016/S0141-0229(96)00180-9
Kragl U, Gygax D, Ghisalba O, Wandrey C: Enzymatic two step synthesis of N-acetylneuraminic acid in the enzyme membrane reactor. Angew Chem Int Ed Eng. 1991, 30: 827-828. 10.1002/anie.199108271. 10.1002/anie.199108271
Maru I, Ohnishi J, Ohta Y, Tsukada Y: Simple and large-scale production of N-acetylneuraminic acid from N-acetyl-D-glucosamine and pyruvate using N-acyl-D-glucosamine 2-epimerase and N-acetylneuraminate lyase. Carbohydr Res. 1998, 306 (4): 575-578. 10.1016/S0008-6215(97)10106-9
Tabata K, Koizumi S, Endo T, Ozaki A: Production of N-acetyl-D-neuraminic acid by coupling bacteria expressing N-acetyl-D-glucosamine 2-epimerase and N-acetyl-D-neuraminic acid synthetase. Enzyme Microb Techn. 2002, 30: 327-333. 10.1016/S0141-0229(01)00515-4. 10.1016/S0141-0229(01)00515-4
Lee YC, Chien HC, Hsu WH: Production of N-acetyl-D-neuraminic acid by recombinant whole cells expressing Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase and Escherichia coli N-acetyl-D-neuraminic acid lyase. J Biotechnol. 2007, 129 (3): 453-460. 10.1016/j.jbiotec.2007.01.027
Ballenweg S: Roempp Online. Thieme Chemistry, Stuttgart. 2005,
Li X, Roseman S: The chitinolytic cascade in Vibrios is regulated by chitin oligosaccharides and a two-component chitin catabolic sensor/kinase. Proc Natl Acad Sci USA. 2004, 101 (2): 627-631. 10.1073/pnas.0307645100
Khoushab F, Yamabhai M: Chitin research revisited. Mar Drugs. 2010, 8 (7): 1988-2012. 10.3390/md8071988
Ferrer J, Paez G, Marmol Z, Ramones E, Garcia H, Forster C: Acid hydrolysis of shrimp-shell wastes and the production of single cell protein from the hydrolysate. Bioresour Technol. 1996, 57: 55-60. 10.1016/0960-8524(96)00057-0. 10.1016/0960-8524(96)00057-0
Lorito M: Chitinolytic enzymes and theire genes. Trichoderma & Gliocladium. Edited by: Harman GE, Kubicek CP. 1998, 2: 73-92. London, UK: Taylor & Francis,
Seidl V, Huemer B, Seiboth B, Kubicek CP: A complete survey of Trichoderma chitinases reveals three distinct subgroups of family 18 chitinases. FEBS J. 2005, 272 (22): 5923-5939. 10.1111/j.1742-4658.2005.04994.x
Martinez D, Berka RM, Henrissat B, Saloheimo M, Arvas M, Baker SE, Chapman J, Chertkov O, Coutinho PM, Cullen D, et al: Genome sequencing and analysis of the biomass-degrading fungus Trichoderma reesei (syn. Hypocrea jecorina). Nat Biotechnol. 2008, 26 (5): 553-560. 10.1038/nbt1403
Watanabe T, Kimura K, Sumiya T, Nikaidou N, Suzuki K, Suzuki M, Taiyoji M, Ferrer S, Regue M: Genetic analysis of the chitinase system of Serratia marcescens 2170. J Bacteriol. 1997, 179 (22): 7111-7117.
Donzelli BG, Ostroff G, Harman GE: Enhanced enzymatic hydrolysis of langostino shell chitin with mixtures of enzymes from bacterial and fungal sources. Carbohydr Res. 2003, 338 (18): 1823-1833. 10.1016/S0008-6215(03)00269-6
Sundaram AK, Pitts L, Muhammad K, Wu J, Betenbaugh M, Woodard RW, Vann WF: Characterization of N-acetylneuraminic acid synthase isoenzyme 1 from Campylobacter jejuni. Biochem J. 2004, 383 (Pt 1): 83-89.
Paccalet T, Bardor M, Rihouey C, Delmas F, Chevalier C, D'Aoust MA, Faye L, Vezina L, Gomord V, Lerouge P: Engineering of a sialic acid synthesis pathway in transgenic plants by expression of bacterial Neu5Ac-synthesizing enzymes. Plant Biotechnol J. 2007, 5 (1): 16-25. 10.1111/j.1467-7652.2006.00211.x
Steiger MG, Mach RL, Mach-Aigner AR: An accurate normalization strategy for RT-qPCR in Hypocrea jecorina (Trichoderma reesei). J Biotechnol. 2010, 145 (1): 30-37. 10.1016/j.jbiotec.2009.10.012
Kuhls K, Lieckfeldt E, Samuels GJ, Kovacs W, Meyer W, Petrini O, Gams W, Borner T, Kubicek CP: Molecular evidence that the asexual industrial fungus Trichoderma reesei is a clonal derivative of the ascomycete Hypocrea jecorina. Proc Natl Acad Sci U S A. 1996, 93 (15): 7755-7760. 10.1073/pnas.93.15.7755
Stricker AR, Trefflinger P, Aro N, Penttilä M, Mach RL: Role of Ace2 (Activator of Cellulases 2) within the xyn2 transcriptosome of Hypocrea jecorina. Fungal Genet Biol. 2008, 45 (4): 436-445. 10.1016/j.fgb.2007.08.005
Mandels M: Applications of cellulases. Biochem Soc Trans. 1985, 13 (2): 414-416.
Roberts WK, Selitrennikoff CP: Plant and Bacterial Chitinases Differ in Antifungal Activity. J Gen Microbiol. 1988, 134: 169-176.
Mach RL, Schindler M, Kubicek CP: Transformation of Trichoderma reesei based on hygromycin B resistance using homologous expression signals. Curr Genet. 1994, 25 (6): 567-570. 10.1007/BF00351679
Gruber F, Visser J, Kubicek CP, de Graaff LH: The development of a heterologous transformation system for the cellulolytic fungus Trichoderma reesei based on a pyrG-negative mutant strain. Curr Genet. 1990, 18 (1): 71-76. 10.1007/BF00321118
Steiger MG, Vitikainen M, Uskonen P, Brunner K, Adam G, Pakula T, Penttilä M, Saloheimo M, Mach RL, Mach-Aigner AR: Transformation system for Hypocrea jecorina (Trichoderma reesei) that favors homologous integration and employs reusable bidirectionally selectable markers. Appl Environ Microbiol. 2011, 77 (1): 114-121. 10.1128/AEM.02100-10
Vann WF, Tavarez JJ, Crowley J, Vimr E, Silver RP: Purification and characterization of the Escherichia coli K1 neuB gene product N-acetylneuraminic acid synthetase. Glycobiology. 1997, 7 (5): 697-701. 10.1093/glycob/7.5.697
Nakamura M, Hara S, Yamaguchi M, Takemori Y, Ohkura Y: 1, 2-Diamino-4, 5-methylenedioxybenzene as a Highly Sensitive Fluorogenic Reagent for a-Keto Acids. Chem Pharm Bull (Tokyo). 1987, 35 (2): 687-692. 10.1248/cpb.35.687. 10.1248/cpb.35.687
Holcapek M, Jirasko R, Lisa M: Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules. J Chromatogr A. 2010, 1217 (25): 3908-3921. 10.1016/j.chroma.2010.02.049
This study was supported by a grant from the Austrian Science Fund FWF (P21287) and a grant from the Vienna University of Technology ("DemoTech", Innovative Project), which are gratefully acknowledged. We thank Michael Schön for assistance with analytical work.
The authors declare that they have no competing interests.
MGS produced and characterized the recombinant strains and contributed to the manuscript. ARMA prepared the manuscript and contributed to the design of the study. RG established enzymatic assays. EER performed HPLC-MS/MS analyses; MDM suggested the target substance and supported analytics; RLM contributed to the design and coordination of the study. All authors critically read the manuscript.
Matthias G Steiger, Astrid R Mach-Aigner contributed equally to this work.
Electronic supplementary material
Additional file 1: tbage and tneub. Coding sequences of the synthetic genes tbage and tneub. The sequences are provided in FASTA format. The Xba I site is underlined, and the Nsi I site is double-underlined. The start codon ATG and the stop codon TAA are presented in bold letters. (PDF 46 KB)
Additional file 2: H. jecorina cultivation on chitin in a bioreactor. Oxygen consumption (pO2; blue line), consumption of the intermediate N-acetylglucosamine (GlcNAc; red line), formation of the product N-acetylneuraminic acid (NeuNAc; pink line), and formation of biomass (given as dry weight, BDW; green line) of the H. jecorina PEC/PSC1 strain cultivated on chitin in a bioreactor for 96 h are displayed. (PDF 22 KB)
About this article
Cite this article
Steiger, M.G., Mach-Aigner, A.R., Gorsche, R. et al. Synthesis of an antiviral drug precursor from chitin using a saprophyte as a whole-cell catalyst. Microb Cell Fact 10, 102 (2011). https://doi.org/10.1186/1475-2859-10-102
- Sialic Acid
- Colloidal Chitin